Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
PubMed record Babula JJ, Bui D, Stevenson HL, Watowich SJ, Neelakantan H
What to Expect During Your Appointment A short assessment to review symptoms and suitability
The research also doesnt extensively cover the long-term consequences of subclinical B12 deficiency or optimal strategies for monitoring and treating intrinsic factor-related B12 deficiency
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
In inflammatory conditions, it helps normalize NO levels to prevent excessive oxidative stress
Although rare, B12 can sometimes cause diarrhea, mild itching, or hives
